CDKN2B anticorps
CDKN2B
Reactivité: Humain
ELISA, IHC
Hôte: Lapin
Polyclonal
unconjugated
N° du produit ABIN2137380
-
-
Antigène
Voir toutes CDKN2B Anticorps
-
CDKN2B
(Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
-
Reactivité
-
Humain
-
Hôte
-
Lapin
-
Clonalité
-
Polyclonal
-
Conjugué
-
Cet anticorp CDKN2B est non-conjugé
-
Application
-
ELISA, Immunohistochemistry (IHC)
-
Purification
-
CDKN2B antibody was purified by Antigen Affinity chromatography
-
Immunogène
-
CDKN2B antibody was raised in Rabbit using Human CDKN2B as the immunogen
-
Isotype
-
IgG
-
Top Product
-
Discover our top product CDKN2B Anticorps primaire
-
-
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Concentration
-
Lot specific
-
Buffer
-
PBS buffer with 0.02 % Sodium Azide and 50 % Glycerol, pH 7.3
-
Agent conservateur
-
Sodium azide
-
Précaution d'utilisation
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles
-
Stock
-
4 °C/-20 °C
-
Stockage commentaire
-
Store at 4 °C for short term storage and -20 °C for long term storage
-
-
Antigène
-
CDKN2B
(Cyclin-Dependent Kinase Inhibitor 2B (p15, Inhibits CDK4) (CDKN2B))
-
Autre désignation
-
CDKN2B (CDKN2B Produits)
-
Synonymes
-
anticorps p14-INK4b, anticorps cdk4l, anticorps ink4b, anticorps mts2, anticorps p15, anticorps p15ink4b, anticorps tp15, anticorps CDK4I, anticorps INK4B, anticorps MTS2, anticorps P15, anticorps TP15, anticorps p15INK4b, anticorps AV083695, anticorps INK4b, anticorps p15(INK4b), anticorps CDKN2A, anticorps cyclin dependent kinase inhibitor 2B, anticorps Cyclin-dependent kinase 4 inhibitor B, anticorps cyclin-dependent kinase inhibitor 2B, anticorps cyclin-dependent kinase inhibitor 2B L homeolog, anticorps cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4), anticorps CDKN2B, anticorps cdn2b, anticorps cdkn2b, anticorps cdkn2b.L, anticorps Cdkn2b
-
Pathways
-
Cycle Cellulaire, Mitotic G1-G1/S Phases
-